Cancel
Kiromic BioPharma
See Linkedin
Kiromic BioPharma Employees
4 people indexed:
-
0l6q2668200@w2005qz.v3s Sign up to see email
-
q3207xqzu4@ew9qswj.5ty Sign up to see email
-
qx95jyyd@dqf8q9z.1qj Sign up to see email
-
xu8fw0v7u@x8t5wnq.6jv Sign up to see email
Kiromic BioPharma Company Information
Kiromic BioPharma, located at 7707 Fannin, Suite 140, Houston, TX 77054, is at the forefront of immuno-oncology research, utilizing its proprietary DIAMOND artificial intelligence platform to expedite the development of cell therapies by improving target identification and reducing development time and costs. The company is developing ALEXIS, a multi-indication allogeneic CAR-T cell therapy platform that employs gamma delta T-cells to target solid tumors. Additionally, Kiromic BioPharma is advancing a non-viral genetic engineering platform named ABBIE, aimed at cutting manufacturing costs and boosting the safety and efficacy of cellular therapies. Its product pipeline includes Deltacel-01, an off-the-shelf gamma delta T-cell (GDT) therapy targeting multiple tumor cell markers, and other allogeneic GDT CAR-T therapies such as Isocel and Procel, which target mesothelin isoform and PD-L1, respectively.
Report inaccurate information
Report inaccurate information
